US 9,808,512 B2
Anti-cell proliferative compounds and methods of use
Michael Kozlowski, San Diego, CA (US)
Assigned to KALOS Therapeutics, San Diego, CA (US)
Filed by Michael Kozlowski, San Diego, CA (US)
Filed on Dec. 29, 2008, as Appl. No. 12/345,023.
Claims priority of provisional application 61/009,382, filed on Dec. 28, 2007.
Prior Publication US 2009/0238817 A1, Sep. 24, 2009
Int. Cl. C07K 7/06 (2006.01); C07K 7/08 (2006.01); A61K 38/00 (2006.01); A61K 38/22 (2006.01)
CPC A61K 38/2242 (2013.01) 12 Claims
 
1. An isolated or purified compound having anti-cell proliferative activity, wherein the compound consists of an 8 to about 45 amino acid residue sequence and wherein the 8 to about 45 amino acid residue sequence includes the sequence F-K-G-Q-L-R-X-I (SEQ ID NO: 1911), wherein X is A, F, I, K, M, N, P, R, T, W, or Y.